Bernard Masquelier

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

Philippe Flandre, Vincent Calvez, Jacques Izopet, 2008, Antimicrobial Agents and Chemotherapy.

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy

Rodolphe Thiébaut, François Dabis, Philippe Morlat, 2008, AIDS.

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

David Dunn, Kholoud Porter, Rodolphe Thiébaut, 2011, The Lancet. Infectious diseases.

Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa.

John Nkengasong, Martine Peeters, Monica Nolan, 2005, AIDS research and human retroviruses.